These losses would cascade through the economy in the form of further reductions of economic demand and extremely tight credit requirements from lenders focused on repairing their own balance sheets.
Cox-2 inhibitors, developed with much hype in the mid-1990s, block an enzyme called cyclooxygenase-2, in so doing shutting off a wide-reaching cascade of biochemical signals that take the form of fats called prostaglandins.